← ANALYST RATINGS · TIPRANKS
Alphatec Holdings (ATEC): analyst forecast and price target
Analyst consensus
Strong Buy11 Buy0 Hold0 Sell
Ratings of 11 analysts in the last 3 months12-month forecast
Based on 11 price targets given in the last 3 months, the average target is $15.18, the highest $24.00, the lowest $12.00. The average is +45.1% from the last price of $10.46.
Analyst ratings 15
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| Thomas Stephan★★★★★★★★★★#3049 · hits 47% · avg +8.4% | Stifel Nicolaus | $10.54 → $13.00+23.3% | Buy | +24.3% | Reiterated | 07.10.26on TipRanks 07:31 | −2.5%next day +1.4% · 5 days +2.8% | ↗ |
| AI xAi Medical - DevicesxAI Grok-3 | TipRanks - xAI | $11.00 → $10.50−4.5% | Hold | +0.4% | Reiterated | 12.09.26on TipRanks 12:05 | — | |
| AI DeepSeek Medical - DevicesDeepSeek R1-0528 | TipRanks - DeepSeek | $10.50 | Hold | +0.4% | Reiterated | 12.09.26on TipRanks 12:05 | — | |
| AI OpenAI Medical - DevicesOpenAI 4o | TipRanks - OpenAI | $11.00 | Hold | +5.2% | Reiterated | 12.09.26on TipRanks 12:05 | — | |
| AI Anthropic Medical - DevicesAnthropic Opus-4.1 | TipRanks - Anthropic | $10.00 → $11.00+10.0% | Hold | +5.2% | Reiterated | 12.09.26on TipRanks 12:05 | — | |
| AI Google Medical - DevicesGemini 2.5Pro | TipRanks - Google | $10.50 → $11.00+4.8% | Hold | +5.2% | Reiterated | 12.09.26on TipRanks 12:05 | — | |
| AI PerPlexity Medical - DevicesPerPlexity SonarPro | TipRanks - PerPlexity | $10.50 → $11.00+4.8% | Hold | +5.2% | Reiterated | 12.09.26on TipRanks 12:05 | — | |
| Keith Hinton★★★★★★★★★★#7123 · hits 80% · avg +7.0% | Freedom Capital Markets | $17.00 | Buy | +62.5% | Reiterated | 12.08.26on TipRanks Sep 27 05:10 | +2.5%next day +0.5% · 5 days +1.7% | ↗ |
| Ben Haynor★★★★★★★★★★#11216 · hits 35% · avg −2.8% | Lake Street | $15.00 | Buy | +43.4% | Reiterated | 05.08.26on TipRanks 09:10 | −7.3%next day −3.6% · 5 days +0.3% | ↗ |
| Patrick Wood★★★★★★★★★★#10768 · hits 50% · avg −2.1% | UBS | $15.00 → $16.00+6.7% | Buy | +53.0% | Assigned | 05.08.26on TipRanks 09:10 | −7.3%next day −3.6% · 5 days +0.3% | ↗ |
| Larry Biegelsen★★★★★★★★★★#2729 · hits 53% · avg +3.8% | Wells Fargo | $14.00 | Buy | +33.8% | Reiterated | 05.08.26on TipRanks 07:41 | −7.3%next day −3.6% · 5 days +0.3% | ↗ |
| Matthew O'Brien★★★★★★★★★★#12031 · hits 41% · avg −4.5% | Piper Sandler | $14.00 | Buy | +33.8% | Reiterated | 05.08.26on TipRanks 07:35 | −7.3%next day −3.6% · 5 days +0.3% | ↗ |
| Vik Chopra★★★★★★★★★★#6076 · hits 45% · avg +1.9% | BMO Capital | $11.00 → $12.00+9.1% | Buy | +14.7% | Assigned | 05.08.26on TipRanks 06:55 | −7.3%next day −3.6% · 5 days +0.3% | ↗ |
| Sean Lee CFA★★★★★★★★★★#10658 · hits 30% · avg −1.5% | H.C. Wainwright | $24.00 | Buy | +129.4% | Reiterated | 05.08.26on TipRanks 06:25 | −7.3%next day −3.6% · 5 days +0.3% | ↗ |
| David Saxon★★★★★★★★★★#6662 · hits 38% · avg +0.8% | Needham | $14.00 | Buy | +33.8% | Reiterated | 05.08.26on TipRanks 05:15 | −7.3%next day −3.6% · 5 days +0.3% | ↗ |
| Mathew Blackman★★★★★★★★★★#2177 · hits 49% · avg +9.2% | TD Cowen | $11.00 → $13.00+18.2% | Buy | +24.3% | Assigned | 05.08.26on TipRanks Aug 4 21:11 | −7.3%next day −3.6% · 5 days +0.3% | ↗ |
| Mason Carrico★★★★★★★★★★#10833 · hits 38% · avg −4.7% | Stephens | $15.00 | Buy | +43.4% | Initiated | 23.07.26on TipRanks Jul 25 21:06 | +3.1%next day +0.5% · 5 days +17.2% | ↗ |
| Thomas Stephan★★★★★★★★★★#3049 · hits 47% · avg +8.4% | Stifel Nicolaus | $16.00 → $13.00−18.8% | Buy | +24.3% | Assigned | 08.07.26on TipRanks 07:25 | −1.5%next day +2.4% · 5 days −3.1% | ↗ |
| Allen Gong★★★★★★★★★★#2251 · hits 46% · avg +14.7% | J.P. Morgan | $24.00 → $16.00−33.3% | Buy | +53.0% | Reiterated | 06.05.26on TipRanks 08:20 | −33.1%next day +11.2% · 5 days +6.9% | ↗ |
| Caitlin Roberts★★★★★★★★★★#1832 · hits 65% · avg +14.7% | Canaccord Genuity | $25.00 → $23.00−8.0% | Buy | +119.9% | Reiterated | 06.05.26on TipRanks 07:20 | −33.1%next day +11.2% · 5 days +6.9% | ↗ |
| Matt Miksic★★★★★★★★★★#2645 · hits 55% · avg +3.9% | Barclays | $27.00 → $24.00−11.1% | Buy | +129.4% | Reiterated | 06.05.26on TipRanks 06:50 | −33.1%next day +11.2% · 5 days +6.9% | ↗ |
| No ratings for this filter. | ||||||||
Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst
Best analysts covering Alphatec Holdings
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $15.18 at a price of $10.32 (+47.1%); now: $15.18 at $10.46 (+45.1%).
PriceAverage targetTop analysts’ target
Recommendation trend
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 14 | 10 | 11 | 6 | 6 | 4 |
| Buy | 0 | 0 | 2 | 7 | 7 | 6 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 29.10.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $0.10 (from $0.07 to $0.12). Last quarter: $0.07.
Sales
Next quarter’s sales estimate — $225M (from $224M to $230M). Last quarter: $214M.
Best top-analyst consensus in the sector · Healthcare
About Alphatec Holdings
- CEO: Patrick S. Miles
- Employees: 913
- 1950 Camino Vida Roble, Carlsbad, CA, 92008, US
- www.atecspine.com
Alphatec Holdings, Inc. is a medical technology firm dedicated to engineering and advancing solutions for the surgical management of spinal conditions. Its product array includes the Alpha InformatiX platform, notably the SafeOp Neural InformatiX System, which is engineered to reduce the likelihood of nerve injury during surgery. For access and positioning, Alphatec offers systems such as the Sigma transforaminal lumbar interbody fusion pedicle-based access system, the Sigma PTP Access and Patient Positioning System, and the Squadron lateral retractor, all designed to optimize surgical outcomes. The company's robust line of spinal fixation devices features the Invictus Spinal Fixation System, capable of addressing various thoracolumbar pathologies, alongside its minimally invasive SingleStep System and adaptable Modular Fixation Systems, which enhance screw modularity. Further fixation options include the OsseoScrew system for spinal column restoration and the comprehensive Arsenal spinal fixation platform, catering to a spectrum of degenerative to deformity procedures. Alphatec also provides anterior lumbar plating solutions like the Aspida Anterior Lumbar Plating System for interbody fusion and the AMP Anti-Migration Plate, in addition to cervical fixation options such as the OCT Spinal Fixation System, the Trestle Luxe Anterior Cervical Plate System, and the Insignia Anterior Cervical Plate System. Its portfolio extends to interbody implants, including IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Implants. A comprehensive suite of biologics is also available, featuring Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier. The company additionally offers EOS imaging products. Alphatec Holdings markets its diverse product range throughout the United States via a network of independent distributors and
Data from the stock’s TipRanks forecast page, read 55 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗